Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests

Go back to Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests
(NASDAQ: NTRA) Delayed: 225.80 -5.61 (2.42%)
Previous Close $231.41    52 Week High $13.80 
Open $231.52    52 Week Low $6.52 
Day High $234.14    P/E N/A 
Day Low $219.50    EPS $0.00 
Volume 877,445